ID   NDi002-A
AC   CVCL_YN04
SY   AML-iPSC c33
DR   hPSCreg; NDi002-A
DR   Wikidata; Q98127503
RX   PubMed=31739201;
CC   From: University of Notre Dame; Notre Dame; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN05 ! NDi002-B
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
RX   PubMed=31739201; DOI=10.1016/j.scr.2019.101587;
RA   Yamasaki A.E., King N.E., Matsui H., Jepsen K., Panopoulos A.D.;
RT   "Two iPSC lines generated from the bone marrow of a
RT   relapsed/refractory AML patient display normal karyotypes and myeloid
RT   differentiation potential.";
RL   Stem Cell Res. 41:101587-101587(2019).
//